SEC Form 4 · accession 0001193125-26-355656
Pediatrix Medical Group, Inc. · MD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sylvia Jean Young
Director
Period of report
Aug 14, 2026
Accepted (ET)
Aug 18, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000893949
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 14, 2026 | D | 18,500 | $26.62 | D | 29,786 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price in Colum 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.51 to $26.80 for a weighted average sales price of $26.62. The reporting person undertakes to provide the issuer, any security holder of the issuer of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.